how to wean off glp 1 Stopping GLP-1s: Weight Regain and Maintenance Tips What to consider when choosing

Among those who did not adhere to their initial treatment within the 1year followup period, 90.5% of metformin initiators and 94.2% of GLP1RA initiators did not start another glucoselowering therapy afterward

Los mecanismos implicados en la mejora del control glucmico por LIRA 3mg y SEMA 2,4mg se relacionan con sus efectos incretnicos y glucagonostticos propios del agonismo de GLP-13 y los derivados de la reduccin ponderal, de masa grasa y sus consecuencias20

Data were recorded using BioDAQ monitoring software 2.1.00, and analysed using DataViewer 2.2.02 and Prism software

2017;153(12401250):e2

The window for market entry remains open partly due to persistent supply constraints among current manufacturers and partly because the addressable patient population continues expanding as clinical evidence mounts for GLP-1 benefits across obesity, diabetes, MASH, cardiovascular disease, and other indications